TP53 and neoplasm: Moreover, through constructing a cytoplasm‐located RYBP mutant (RYBPmut), one study indicated that RYBPmut has enhanced potential to promote tumour apoptosis and inhibit tumour cell proliferation via p53‐dependent and caspase 8‐dependent mechanisms compared with wild‐type RYBP 2.